The overarching goal of the Einstein/Rockefeller/CUNY CFAR (ERC-CFAR) Developmental Core is to support the career development of early stage investigators (ESIs) of the three participating institutions through an effective mentoring process coupled with a peer-reviewed Catalytic grants program and ongoing support for their scientific growth via their participation in programs specifically tailored for ESIs. The objectives of the ERC-CFAR Developmental core are centered on mentoring ESIs, catalyzing trans-institutional collaborative HIV/AIDS research in the ERC-CFAR, supporting Scientific Working Group (SWG) efforts to catalyze research in their topic areas, facilitating scientific communication among ERC-CFAR investigators and enhancing international HIV/AIDS research. We will accomplish these goals through the following six specific Aims.
In Aim 1 we will provide individually tailored mentoring to ESIs and facilitate their development into independently funded researchers by pairing ESIs with established investigators (EIs), by providing both individual and group- level mentoring to help them develop NIH K- or R- type grants and by assisting senior level ESIs with transition to an R01 funding.
In Aim 2, we will support ESIs engaged in AIDS research in the ERC-CFAR via catalytic and micro grants, which will also be used to promote trans-institutional collaborations and to support SWG priorities.
In Aim 3, we will stimulate intra- and trans-institutional, collaborative AIDS research at the participating institutions by awarding joint catalytic grants. We will proactively recruit non-AIDS EIs engaged in cutting edge research into AIDS research.
In Aim 4, we will facilitate scientific communication among ERC- CFAR investigators by organizing a bi-weekly Trans-institutional ERC-CFAR research seminar series and the biweekly Clinical AIDS Grand Rounds series both of which are simulcast to all three institutions, ERC-CFAR Invited Speaker Seminars and Annual ERC-CFAR Scientific Retreats to foster scientific interaction.
In Aim 5, we will promote AIDS Research in the ERC-CFAR via integration with other Einstein programs such as WIHS, the institutional AIDS T32 and the Geographic Medicine T32 programs and African HIV/AIDS research programs.
In Aim 6, we will facilitate and mentor ESIs in conducting community participatory and behavioral AIDS research via collaboration with the Behavioral Science Core.
|Bhalakia, Avni M; Talib, Hina J; Choi, Jaeun et al. (2018) Acceptance of Routine HIV Testing by Hospitalized Adolescents and Young Adults. Hosp Pediatr 8:187-193|
|Hannaford, Alisse; Lipshie-Williams, Madeleine; Starrels, Joanna L et al. (2018) The Use of Online Posts to Identify Barriers to and Facilitators of HIV Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men: A Comparison to a Systematic Review of the Peer-Reviewed Literature. AIDS Behav 22:1080-1095|
|Lu, Ching-Lan; Pai, Joy A; Nogueira, Lilian et al. (2018) Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption. Proc Natl Acad Sci U S A 115:E11341-E11348|
|Grov, Christian; Jonathan Rendina, H; Patel, Viraj V et al. (2018) Prevalence of and Factors Associated with the Use of HIV Serosorting and Other Biomedical Prevention Strategies Among Men Who Have Sex with Men in a US Nationwide Survey. AIDS Behav 22:2743-2755|
|Cohen, Yehuda Z; Lorenzi, Julio C C; Krassnig, Lisa et al. (2018) Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117. J Exp Med 215:2311-2324|
|Cohen, Yehuda Z; Lorenzi, Julio C C; Seaman, Michael S et al. (2018) Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells. J Virol 92:|
|Cohen, Yehuda Z; Caskey, Marina (2018) Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection. Curr Opin HIV AIDS 13:366-373|
|Patel, Viraj V; Dange, Alpana; Rawat, Shruta et al. (2018) Barriers to HIV Testing Among Men Who Have Sex With Men in India Reached Online: Implications for Interventions. J Acquir Immune Defic Syndr 78:e30-e34|
|Liu, Yanyan; Ndumnego, Okechukwu C; Chen, Tingting et al. (2018) Soluble CD14 as a Diagnostic Biomarker for Smear-Negative HIV-Associated Tuberculosis. Pathogens 7:|
|Bar-On, Yotam; Gruell, Henning; Schoofs, Till et al. (2018) Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals. Nat Med 24:1701-1707|
Showing the most recent 10 out of 27 publications